Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic
17th treatment shown to reduce risk in
March 2021 *, now known with p = 0.0000013 from 26 studies.
|
Review of data supporting the use of probiotics for COVID-19 and mechanisms of action.
Baud et al., 8 May 2020, peer-reviewed, 5 authors.
Abstract: OPINION
published: 08 May 2020
doi: 10.3389/fpubh.2020.00186
Using Probiotics to Flatten the Curve
of Coronavirus Disease COVID-2019
Pandemic
David Baud 1 , Varvara Dimopoulou Agri 2 , Glenn R. Gibson 3 , Gregor Reid 4,5 and
Eric Giannoni 2*
1
Materno-Fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, University of
Lausanne, Lausanne, Switzerland, 2 Clinic of Neonatology, Department Woman-Mother-Child, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland, 3 Food and Nutritional Sciences, St Joseph’s Hospital, The University of
Reading, Reading, United Kingdom, 4 Department of Microbiology and Immunology, The University of Western Ontario,
London, ON, Canada, 5 Canadian R&D Centre for Human Microbiome and Probiotics, Lawson Health Research Institute,
London, ON, Canada
Keywords: COVID 19, probiotics, prebiotics, SARS-CoV-2, pandemics, coronavirus, respiratory infection
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers.
Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit
